Gene · 406921
Papers4,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,661 to 1,680 of 4,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adipose-Derived Mesenchymal Stromal Cells Treated with Interleukin 1 Beta Produced Chondro-Protective Vesicles Able to Fast Penetrate in Cartilage. | Cells | 2021 | 34066077 | PubTator, text mining | PubMed |
| Human Genomics and the Biocultural Origin of Music. | Int J Mol Sci | 2021 | 34065521 | PubTator, text mining | PubMed |
| Potential clinical biomarkers in rheumatoid arthritis with an omic approach. | Auto Immun Highlights | 2021 | 34059137 | PubTator, text mining | PubMed |
| Post-transcriptional modulators and mediators of the circadian clock. | Chronobiol Int | 2021 | 34056966 | PubTator, text mining | PubMed |
| NEAT1 siRNA Packed with Chitosan Nanoparticles Regulates the Development of Colon Cancer Cells via lncRNA NEAT1/miR-377-3p Axis. | Biomed Res Int | 2021 | 34055978 | PubTator, text mining | PubMed |
| miR-212/132-Enriched Extracellular Vesicles Promote Differentiation of Induced Pluripotent Stem Cells Into Pancreatic Beta Cells. | Front Cell Dev Biol | 2021 | 34055806 | PubTator, text mining | PubMed |
| Exosomes: Innocent Bystanders or Critical Culprits in Neurodegenerative Diseases. | Front Cell Dev Biol | 2021 | 34055771 | PubTator, text mining | PubMed |
| Diagnostic and Therapeutic Potential of Exosomal MicroRNAs for Neurodegenerative Diseases. | Neural Plast | 2021 | 34054944 | PubTator, text mining | PubMed |
| LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P/SREBP1 signaling. | Toxicol Lett | 2021 | 34052307 | PubTator, text mining | PubMed |
| miR-520c-3p regulates IL-1β-stimulated human chondrocyte apoptosis and cartilage degradation by targeting GAS2. | J Orthop Surg Res | 2021 | 34051811 | PubTator, text mining | PubMed |
| A 3D Fiber-Hydrogel Based Non-Viral Gene Delivery Platform Reveals that microRNAs Promote Axon Regeneration and Enhance Functional Recovery Following Spinal Cord Injury. | Adv Sci (Weinh) | 2021 | 34050637 | PubTator, text mining | PubMed |
| Key Markers and Epigenetic Modifications of Dental-Derived Mesenchymal Stromal Cells. | Stem Cells Int | 2021 | 34046069 | PubTator, text mining | PubMed |
| Role of long noncoding RNA taurine-upregulated gene 1 in cancers. | Mol Med | 2021 | 34039257 | PubTator, text mining | PubMed |
| [Retracted] Decreased microRNA‑132 and its function in human non‑small cell lung cancer. | Mol Med Rep | 2021 | 34036381 | PubTator, text mining | PubMed |
| MicroRNA-552 Accelerates the Progression of Gastric Cancer by Targeting FOXO1 and Regulating PI3K/AKT Pathway. | J Oncol | 2021 | 34035814 | PubTator, text mining | PubMed |
| MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro. | Sci Rep | 2021 | 34035375 | PubTator, text mining | PubMed |
| Circ-sirt1 inhibits growth and invasion of gastric cancer by sponging miR-132-3p/miR-212-3p and upregulating sirt1 expression. | Neoplasma | 2021 | 34034499 | PubTator, text mining | PubMed |
| Restoring miR-132 expression rescues adult hippocampal neurogenesis and memory deficits in Alzheimer's disease. | Cell Stem Cell | 2021 | 34033742 | PubTator, text mining | PubMed |
| Dynamic alteration in miRNA and mRNA expression profiles at different stages of chronic arsenic exposure-induced carcinogenesis in a human cell culture model of skin cancer. | Arch Toxicol | 2021 | 34032870 | PubTator, text mining | PubMed |
| Inhibition of microRNA-129-2-3p protects against refractory temporal lobe epilepsy by regulating GABRA1. | Brain Behav | 2021 | 34029007 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406921/papers?page=84